1105187-36-7 Usage
General Description
Methyl 3-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate is a chemical compound with the molecular formula C8H5BrNO2S. Although limited information is available on its specific physical and chemical properties, it is likely characterized by a high reactivity due to the presence of a bromine atom, which is commonly involved in a range of chemical reactions. The compound comprises a methyl ester group (methoxy-carbonyl), making it susceptible to hydrolysis under both acidic and basic conditions. Additionally, its structure suggests that it would display properties typical of heterocyclic compounds. More detailed information, including its precise physical properties, pharmacological potential or possible industrial applications, would require specific scientific investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 1105187-36-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,1,8 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1105187-36:
(9*1)+(8*1)+(7*0)+(6*5)+(5*1)+(4*8)+(3*7)+(2*3)+(1*6)=117
117 % 10 = 7
So 1105187-36-7 is a valid CAS Registry Number.
1105187-36-7Relevant articles and documents
Discovery of 4H-thieno[3,2-b]pyrrole derivatives as potential anticancer agents
Fang, Bo,Hu, Chunsheng,Ding, Yong,Qin, Hongxia,Luo, Yafei,Xu, Zhigang,Meng, Jiangping,Chen, Zhongzhu
, p. 1610 - 1627 (2021/06/06)
In this study, we describe the discovery of the 4H-thieno[3,2-b]pyrrole derivatives as an useful scaffold to obtain potent lead compounds for the treatment of colon cancer. We first started with the 4H-thieno[3,2-b]pyrrole derivatives which come from comp
INHIBITORS OF METALLO-BETA-LACTAMASES
-
Paragraph 00158, (2018/12/13)
The present invention relates to certain compounds that function as inhibitors of bacterial metallo-beta-lactamases. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of a bacterial infection.